Bioengineers at Harvard have developed a gel-based sponge that can be molded to any shape, loaded with drugs or stem cells, compressed to a fraction of its size, and delivered via injection. Once inside the body, it pops back to its original shape and gradually releases its cargo, before safely degrading.
The biocompatible technology, revealed this week in the Proceedings of the National Academy of Sciences, amounts to a prefabricated healing kit for a range of minimally invasive therapeutic applications, including regenerative medicine.
"What we've created is a three-dimensional structure that you could use to influence the cells in the tissue surrounding it and perhaps promote tissue formation," explains principal investigator David J. Mooney, Robert P. Pinkas Family Professor of Bioengineering at the Harvard School of Engineering and Applied Sciences (SEAS) and a Core Faculty Member at the Wyss Institute for Biologically Inspired Engineering at Harvard.
"The simplest application is when you want bulking," Mooney explains. "If you want to introduce some material into the body to replace tissue that's been lost or that is deficient, this would be ideal. In other situations, you could use it to transplant stem cells if you're trying to promote tissue regeneration, or you might want to transplant immune cells, if you're looking at immunotherapy."
Consisting primarily of alginate, a seaweed-based jelly, the injectable sponge contains networks of large pores, which allow liquids and large molecules to easily flow through it. Mooney and his research team demonstrated that live cells can be attached to the walls of this network and delivered intact along with the sponge, through a small-bore needle. Mooney's team also demonstrated that the sponge can hold large and small proteins and drugs within the alginate jelly itself, which are gradually released as the biocompatible matrix starts to break down inside the body.
Normally, a scaffold like this would have to be implanted surgically. Gels can also be injected, but until now those gels would not have carried any inherent structure; they would simply flow to fill whatever space was available.
"Our scaffolds can be designed in any size and shape, and injected in situ as a safe, preformed, fully characterized, sterile, and controlled delivery device for cells and drugs," says lead author Sidi Bencherif, a postdoctoral research associate in Mooney's lab at SEAS and at the Wyss Institute.
Bencherif and his colleagues pushed pink squares, hearts, and stars through a syringe to demonstrate the versatility and robustness of their gel.
The spongelike gel is formed through a freezing process called cryogelation. As the water in the alginate solution starts to freeze, pure ice crystals form, which makes the surrounding gel more concentrated as it sets. Later on, the ice crystals melt, leaving behind a network of pores. By carefully calibrating this mixture and the timing of the freezing process, Mooney, Bencherif, and their colleagues found that they could produce a gel that is extremely strong and compressible, unlike most alginate gels, which are brittle.
The resulting "cryogel" fills a gap that has previously been unmet in biomedical engineering.
"These injectable cryogels will be especially useful for a number of clinical applications including cell therapy, tissue engineering, dermal filler in cosmetics, drug delivery, and scaffold-based immunotherapy," says Bencherif. "Furthermore, the ability of these materials to reassume specific, pre-defined shapes after injection is likely to be useful in applications such as tissue patches where one desires a patch of a specific size and shape, and when one desires to fill a large defect site with multiple smaller objects. These could pack in such a manner to leave voids that enhance diffusional transport to and from the objects and the host, and promote vascularization around each object."
The next step in the team's research is to perfect the degradation rate of the scaffold so that it breaks down at the same rate at which newly grown tissue replaces it. Harvard's Office of Technology Development has filed patent applications on the invention and is actively pursuing licensing and commercialization opportunities.
Harvard University: http://www.harvard.edu
This press release was posted to serve as a topic for discussion. Please comment below. We try our best to only post press releases that are associated with peer reviewed scientific literature. Critical discussions of the research are appreciated. If you need help finding a link to the original article, please contact us on twitter or via e-mail.
Sun seekers who leave northern Europe for warmer climes are marginally less happy than those left behind, a study found.
The deadly Middle East Respiratory Syndrome has neither no definitive origin, nor a known cure, so global public health officials are becoming increasingly concerned by the Saudi government's sluggish response as the number of human cases continues to rise
Supply became contaminated as it passed through giant network of lead pipes that distributed water around city, scientists believe
As the cold season dribbles relentlessly onward, its worth considering who is or is not to blame for your misery
Last year a scientist said he'd found a new form of botulinum toxin, and was keeping details secret to keep the recipe from terrorists. But other science and public health labs were shut out, too.
Flu cases across the US can be accurately estimated using Wikipedia searches, and fluey tweets from Twitter users also give the game away
Workers who have a creative outlet outside the office are more likely to be creative problem solvers on the job, a study suggests. Oh, and they have more fun.
Scientists to grow a crop of camelina plants genetically modified to produce fish oils that could be used in health supplements Continue reading...
Kent Kiehl has been interviewing psychopaths for more than 20 years. More recently he's acquired a mobile MRI scanner and permission to scan the brains of New Mexico state prison inmates. He talked with WIRED about what's different in the brains of psychopaths and why he views psychopathy as a preventable mental disorder.
In Snakes, Sunrises, and Shakespeare, evolutionary psychology pioneer Gordon H. Orians traces the roots of today's human quirks in the minds of our ancestors